文献速递免疫规划

三例XLA患者对mRNA COVID-19疫苗接种的反应

Response to mRNA COVID-19 vaccination in three XLA patients.
PubMed 文献 · Vaccine · 2022-08-03

本文报告三例接受mRNA COVID-19疫苗的X连锁无丙种球蛋白血症(XLA)患者,其中一例出现阳性抗体反应;尽管XLA患者通常不产生抗体应答,但可产生T细胞应答,部分患者也可能产生阳性抗体反应,因此应鼓励所有XLA患者接种COVID-19疫苗。

要点

  • XLA患者通常缺乏可测量的抗体应答,但可对COVID-19疫苗产生T细胞应答。
  • 本文报告的三例XLA患者中,一例接种mRNA COVID-19疫苗后出现阳性抗体反应。
  • 作者认为应鼓励所有XLA患者接种COVID-19疫苗。

核心结论

  • 除T细胞应答外,部分XLA患者可能产生阳性抗体反应,因此应鼓励所有XLA患者接种COVID-19疫苗。

研究设计与样本

  • 本文报告三例接受mRNA COVID-19疫苗的X连锁无丙种球蛋白血症(XLA)患者。

主要发现

  • 三例XLA患者中,一例接种mRNA COVID-19疫苗后出现阳性抗体反应。

临床怎么用

  • 作者认为,应鼓励所有XLA患者接种COVID-19疫苗。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

X-linked agammaglobulinemia (XLA) is an inborn error of immunity characterized by insufficient production of immunoglobulins and lack of measurable antibody response to vaccines. The rise of novel infections limits the protective effect of immunoglobulin replacement in immunodeficient patients though. While XLA patients are not expected to mount an antibody response to COVID-19 vaccination, it has been demonstrated that XLA patients can mount a T-cell response to COVID-19 vaccines, similar to the influenza vaccine. We present three patients with XLA who received an mRNA COVID-19 vaccine. One patient demonstrated positive antibody response. Many XLA patients do not receive routine vaccinations due to ongoing immunoglobulin replacement therapy and lack of native antibody production, but in addition to T-cell response to vaccination, select XLA patients may mount a positive antibody response. Therefore, COVID-19 vaccination should be encouraged for all XLA patients.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Squire JD, Joshi AY. Response to mRNA COVID-19 vaccination in three XLA patients. Vaccine. 2022. PMID: 35934578. doi:10.1016/j.vaccine.2022.07.046

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。